Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period. - Wikidata - wikimedia - TriplyDB

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

http://www.wikidata.org/entity/Q30808061

about

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Antifungal Susceptibility Analysis of Clinical Isolates of Candida parapsilosis in Iran.Current trends in candidemia and species distribution among adults: Candida glabrata surpasses C. albicans in diabetic patients and abdominal sources.Diagnosis and management of a fatal case of sepsis caused by Candida parapsilosis sensu stricto in a neonate with omphalocele.

P2860

Q37242216-B61A4115-E380-4665-A2AB-FC1475396865 Q37580801-DF444984-3D69-4229-81DF-04EE0B018B48 Q40689558-E4417DCA-7D80-44FE-9834-BADD607A1597 Q46517878-1A32E02F-9EA1-47F2-8444-D1954D332BE4 Q48514102-5E13043B-D095-419B-A096-D20EBD5D19CD

P2860

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

http://www.wikidata.org/entity/Q30808061

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

@ast

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

@en

type

label

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

@ast

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

@en

prefLabel

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

@ast

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

@en

P1433

Q30808061-87C144FD-05CA-47D2-9FAD-789D1C5B676A

P1476

Q30808061-14585CDD-A936-4248-9CFA-AD9CBA1FBE8E

P2093

Q30808061-B0336067-9D5E-4568-8767-85555D2637C1

P2860

Q30808061-02272B71-6AEE-476E-842E-DF99699ECB45

Q30808061-02518AD8-E85C-46E3-A86C-1DF403B8E450

Q30808061-062676E6-B798-4A61-A7C9-441D6A0BB56F

Q30808061-11EEECBD-2CBC-45DB-889A-A5D229D13F22

Q30808061-16EB68F4-0959-4716-99DB-86A2068721AF

Q30808061-19C746BA-F5B7-4F18-AC56-94EB7DE49291

Q30808061-25CF9ACB-AA3E-4132-A69E-D3C1704AA3F1

Q30808061-3332EAC6-0814-45E1-8D4A-50BA34B3068E

Q30808061-3F1F2AE8-8D95-4B3B-A671-D0E6525739EB

Q30808061-4407FB48-4BCA-49E8-A8E7-F379053C8F91

P304

Q30808061-B4FBF98D-726E-4448-A359-4FE9FF5D4098

P31

Q30808061-80FBE563-5A13-4E67-BD8C-AAE6292EC88E

P356

Q30808061-2A87F6C3-FE74-4936-9053-3CDE0EDD4F20

P433

Q30808061-29BA107A-E7E3-45D2-89F4-28108C123BD0

P478

Q30808061-6102BD8C-6B5E-473D-AF5F-AD85C6C9C2AB

P50

Q30808061-31E2048D-4ACC-414E-B2A2-8A68F7DF098B

Q30808061-3348B511-1BCE-4F3A-B29B-BA79C532A10F

Q30808061-A01C7903-955B-480E-A432-16E0E58CE57B

P577

Q30808061-9C7B25A0-FC12-431F-9640-0ABC2A4B24C6

P5875

Q30808061-D18A77CD-8E55-444B-B4E9-E7491DE9FE58

P698

Q30808061-FD9A9383-4217-4730-992A-7A0B14A5FECE

P356

00365548.2014.900190

P1433

Scandinavian Journal of Infectious Diseases

P1476

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

@en

P2093

Francesca March

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy

Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion

[Age group, geographical incidence and patterns of antifungal susceptibility of Candida species causing candidemia in the Spanish paediatric population].

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

P304

454-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00365548.2014.900190

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Ferran Sanchez-Reus

Mar Martí-Carrizosa

P577

2014-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261880596

http://www.w3.org/2001/XMLSchema#string

P698

24762093

http://www.w3.org/2001/XMLSchema#string